Global and China Nuclear Medicine/Radiopharmaceuticals Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Nuclear Medicine/Radiopharmaceuticals industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Jaco

    • Shanghai Atom Kexing

    • Ciaeriar

    • China Isotope & Radiation

    • Dongcheng

    • Advanced Molecular-imaging Solution

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Diagnostic

    • Therapeutic

    Application:

    • Oncology

    • Thyroid

    • Cardiology

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Nuclear Medicine/Radiopharmaceuticals Industry Overview

      • 1.1.1 Nuclear Medicine/Radiopharmaceuticals Market Scope and Market Segments

      • 1.1.2 Nuclear Medicine/Radiopharmaceuticals Industry Characteristics

      • 1.1.3 Global and China Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Nuclear Medicine/Radiopharmaceuticals Production Value and Growth Rate (2017-2028)

    • 1.2 Global Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Diagnostic

      • 1.2.2 Therapeutic

    • 1.3 Global Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Oncology

      • 1.3.2 Thyroid

      • 1.3.3 Cardiology

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Nuclear Medicine/Radiopharmaceuticals Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Nuclear Medicine/Radiopharmaceuticals Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Nuclear Medicine/Radiopharmaceuticals Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Nuclear Medicine/Radiopharmaceuticals Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Nuclear Medicine/Radiopharmaceuticals Industry Porter's Five Forces Model Analysis

      • 2.2.3 Nuclear Medicine/Radiopharmaceuticals Industry PEST Analysis

    • 2.3 Nuclear Medicine/Radiopharmaceuticals Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Nuclear Medicine/Radiopharmaceuticals Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Nuclear Medicine/Radiopharmaceuticals Industry

    Chapter 3 Global and China Nuclear Medicine/Radiopharmaceuticals Market, by Manufacturer

    • 3.1 Global and China Nuclear Medicine/Radiopharmaceuticals Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Nuclear Medicine/Radiopharmaceuticals Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Nuclear Medicine/Radiopharmaceuticals Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Nuclear Medicine/Radiopharmaceuticals Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Nuclear Medicine/Radiopharmaceuticals Market Top 3 Players

    Chapter 4 Global and China Nuclear Medicine/Radiopharmaceuticals Market, by Type (2017-2028)

    • 4.1 Nuclear Medicine/Radiopharmaceuticals Market Trend, by Type

    • 4.2 Global Nuclear Medicine/Radiopharmaceuticals Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Nuclear Medicine/Radiopharmaceuticals Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Nuclear Medicine/Radiopharmaceuticals Price Trend, by Type (2017-2028)

    • 4.3 China Nuclear Medicine/Radiopharmaceuticals Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Nuclear Medicine/Radiopharmaceuticals Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Nuclear Medicine/Radiopharmaceuticals Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Nuclear Medicine/Radiopharmaceuticals Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Nuclear Medicine/Radiopharmaceuticals Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Nuclear Medicine/Radiopharmaceuticals Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Nuclear Medicine/Radiopharmaceuticals Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Nuclear Medicine/Radiopharmaceuticals Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Nuclear Medicine/Radiopharmaceuticals Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Nuclear Medicine/Radiopharmaceuticals Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Nuclear Medicine/Radiopharmaceuticals Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Nuclear Medicine/Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Nuclear Medicine/Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Nuclear Medicine/Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Nuclear Medicine/Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Nuclear Medicine/Radiopharmaceuticals Market Analysis

    • 7.1 North America Nuclear Medicine/Radiopharmaceuticals Market, by Type

    • 7.2 North America Nuclear Medicine/Radiopharmaceuticals Market, by Application

    • 7.3 North America Nuclear Medicine/Radiopharmaceuticals Market Analysis and Forecast, by Country

      • 7.3.1 United States Nuclear Medicine/Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Nuclear Medicine/Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Nuclear Medicine/Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Nuclear Medicine/Radiopharmaceuticals Market Analysis

    • 8.1 Europe Nuclear Medicine/Radiopharmaceuticals Market, by Type

    • 8.2 Europe Nuclear Medicine/Radiopharmaceuticals Market, by Application

    • 8.3 Europe Nuclear Medicine/Radiopharmaceuticals Market Analysis and Forecast, by Country

      • 8.3.1 Germany Nuclear Medicine/Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Nuclear Medicine/Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Nuclear Medicine/Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Nuclear Medicine/Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Nuclear Medicine/Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Nuclear Medicine/Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Nuclear Medicine/Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Nuclear Medicine/Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Nuclear Medicine/Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Nuclear Medicine/Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Nuclear Medicine/Radiopharmaceuticals Market Analysis

    • 9.1 APAC Nuclear Medicine/Radiopharmaceuticals Market, by Type

    • 9.2 APAC Nuclear Medicine/Radiopharmaceuticals Market, by Application

    • 9.3 APAC Nuclear Medicine/Radiopharmaceuticals Market Analysis and Forecast, by Country

      • 9.3.1 China Nuclear Medicine/Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Nuclear Medicine/Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Nuclear Medicine/Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Nuclear Medicine/Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Nuclear Medicine/Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Nuclear Medicine/Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Analysis

    • 10.1 Latin America, Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market, by Type

    • 10.2 Latin America, Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market, by Application

    • 10.3 Latin America, Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Nuclear Medicine/Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Nuclear Medicine/Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Nuclear Medicine/Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Nuclear Medicine/Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Nuclear Medicine/Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Nuclear Medicine/Radiopharmaceuticals Company Profiles

      • 11.1 Jaco

        • 11.1.1 Jaco Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Jaco Nuclear Medicine/Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.1.3 Jaco Nuclear Medicine/Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Shanghai Atom Kexing

        • 11.2.1 Shanghai Atom Kexing Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.2.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Ciaeriar

        • 11.3.1 Ciaeriar Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.3.3 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 China Isotope & Radiation

        • 11.4.1 China Isotope & Radiation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.4.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Dongcheng

        • 11.5.1 Dongcheng Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Dongcheng Nuclear Medicine/Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.5.3 Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Advanced Molecular-imaging Solution

        • 11.6.1 Advanced Molecular-imaging Solution Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.6.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Nuclear Medicine/Radiopharmaceuticals Industry Investment Prospect and Risk Assessment

    • 12.1 Nuclear Medicine/Radiopharmaceuticals Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Nuclear Medicine/Radiopharmaceuticals Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure China Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Global Nuclear Medicine/Radiopharmaceuticals Production Value and Growth Rate (2017-2028)

    • Figure China Nuclear Medicine/Radiopharmaceuticals Production Value and Growth Rate (2017-2028)

    • Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate of Diagnostic (2017-2028)

    • Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate of Therapeutic (2017-2028)

    • Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate of Oncology (2017-2028)

    • Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate of Thyroid (2017-2028)

    • Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate of Cardiology (2017-2028)

    • Figure North America Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Nuclear Medicine/Radiopharmaceuticals Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Nuclear Medicine/Radiopharmaceuticals Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Nuclear Medicine/Radiopharmaceuticals Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Nuclear Medicine/Radiopharmaceuticals Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Nuclear Medicine/Radiopharmaceuticals Market Share, by Manufacturer in 2021

    • Figure Global and China Nuclear Medicine/Radiopharmaceuticals Market Share, by Manufacturer in 2022

    • Table Global Nuclear Medicine/Radiopharmaceuticals Sales Volume, by Type (2017-2028)

    • Table Global Nuclear Medicine/Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table Global Nuclear Medicine/Radiopharmaceuticals Sales Value, by Type (2017-2028)

    • Table Global Nuclear Medicine/Radiopharmaceuticals Sales Value Share, by Type (2017-2028)

    • Figure Global Nuclear Medicine/Radiopharmaceuticals Price Trend, by Type (2017-2028)

    • Table China Nuclear Medicine/Radiopharmaceuticals Sales Volume, by Type (2017-2028)

    • Table China Nuclear Medicine/Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure China Nuclear Medicine/Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table China Nuclear Medicine/Radiopharmaceuticals Sales Value, by Type (2017-2028)

    • Table China Nuclear Medicine/Radiopharmaceuticals Sales Value Share, by Type (2017-2028)

    • Figure China Nuclear Medicine/Radiopharmaceuticals Price Trend, by Type (2017-2028)

    • Table Global Nuclear Medicine/Radiopharmaceuticals Sales Volume, by Application (2017-2028)

    • Table Global Nuclear Medicine/Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Table Global Nuclear Medicine/Radiopharmaceuticals Sales Value, by Application (2017-2028)

    • Table Global Nuclear Medicine/Radiopharmaceuticals Sales Value Share, by Application (2017-2028)

    • Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Value Share, by Application (2017-2028)

    • Table China Nuclear Medicine/Radiopharmaceuticals Sales Volume, by Application (2017-2028)

    • Table China Nuclear Medicine/Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure China Nuclear Medicine/Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Table China Nuclear Medicine/Radiopharmaceuticals Sales Value, by Application (2017-2028)

    • Table China Nuclear Medicine/Radiopharmaceuticals Sales Value Share, by Application (2017-2028)

    • Figure China Nuclear Medicine/Radiopharmaceuticals Sales Value Share, by Application (2017-2028)

    • Figure China Nuclear Medicine/Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • Figure North America Nuclear Medicine/Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Nuclear Medicine/Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Nuclear Medicine/Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • Table North America Nuclear Medicine/Radiopharmaceuticals Sales Volume, by Type (2017-2028)

    • Table North America Nuclear Medicine/Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure North America Nuclear Medicine/Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table North America Nuclear Medicine/Radiopharmaceuticals Sales Volume, by Application (2017-2028)

    • Table North America Nuclear Medicine/Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure North America Nuclear Medicine/Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure United States Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure United States Nuclear Medicine/Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Canada Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Nuclear Medicine/Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Nuclear Medicine/Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Table Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume, by Type (2017-2028)

    • Table Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume, by Application (2017-2028)

    • Table Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure Germany Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Nuclear Medicine/Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure UK Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure UK Nuclear Medicine/Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure France Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure France Nuclear Medicine/Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Italy Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Nuclear Medicine/Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Nuclear Medicine/Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Spain Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Nuclear Medicine/Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Nuclear Medicine/Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Poland Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Nuclear Medicine/Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Russia Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Nuclear Medicine/Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Nuclear Medicine/Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Table APAC Nuclear Medicine/Radiopharmaceuticals Sales Volume, by Type (2017-2028)

    • Table APAC Nuclear Medicine/Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure APAC Nuclear Medicine/Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table APAC Nuclear Medicine/Radiopharmaceuticals Sales Volume, by Application (2017-2028)

    • Table APAC Nuclear Medicine/Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure APAC Nuclear Medicine/Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure China Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure China Nuclear Medicine/Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Japan Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Nuclear Medicine/Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Nuclear Medicine/Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure India Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure India Nuclear Medicine/Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Nuclear Medicine/Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Nuclear Medicine/Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Nuclear Medicine/Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Nuclear Medicine/Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Nuclear Medicine/Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Nuclear Medicine/Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Nuclear Medicine/Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Table Jaco Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Jaco Product Profiles, Application and Specification

    • Table Jaco Nuclear Medicine/Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Shanghai Atom Kexing Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Shanghai Atom Kexing Product Profiles, Application and Specification

    • Table Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ciaeriar Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ciaeriar Product Profiles, Application and Specification

    • Table Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table China Isotope & Radiation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table China Isotope & Radiation Product Profiles, Application and Specification

    • Table China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Dongcheng Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Dongcheng Product Profiles, Application and Specification

    • Table Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Advanced Molecular-imaging Solution Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Advanced Molecular-imaging Solution Product Profiles, Application and Specification

    • Table Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.